Latest Breaking News On - Regenstrief institute inc - Page 1 : comparemela.com
Screening for colorectal cancer presents a unique opportunity unavailable for most other types of cancers. Screening allows for the detection of both precancerous polyps and cancer, enabling clinicians to intervene and reduce the chances of future development of new or more advanced malignancy. However, gaps in the colorectal screening process exist. One of the most critical gaps, according to an editorial published in JAMA Network Open by Regenstrief Institute Research Scientists Jennifer Maratt, M.D., M.S., and Thomas Imperiale,M.D., and Duke University colleague David A. Leiman, M.D., MSHP, is the lack of timely follow-up with a colonoscopy after a positive stool-based test.
Davida-leimanThomas-imperialeThomasf-imperialeJennifer-marattJenniferk-marattDivision-of-gastroenterologyIu-school-of-medicineDuke-clinical-research-instituteRichardl-roudebush-va-medical-centerHealth-informationDevelopment-centerRegenstrief-institute-inc